advertisement

Topcon

Abstract #109993 Published in IGR 24-1

Examining Bias in Published Surgical Glaucoma Clinical Trials

Michael R; McIntyre S; Zhang H; Cape L; Toren A
Journal of Glaucoma 2023; 0:


PRCIS: Our results demonstrate that, among randomized clinical trials examining the use of surgical treatments for glaucoma, the majority were not registered. Publication bias was less likely. More than one third of registered trials presented outcome reporting bias. PURPOSE: Despite the optimum of quality evidence provided by randomized controlled trials (RCTs), biases may be introduced and hinder their application. The primary objective of this study was to investigate outcome reporting bias (ORB) and publication bias (PB) in RCTs assessing surgical treatments of glaucoma, as well as their registration status. METHODS: A literature review was conducted in MEDLINE, EMBASE and CENTRAL databases. Inclusion criteria were RCTs published in English between 2007 and 2021 that focused on surgical treatments of patients of all ages with glaucoma or elevated intraocular pressure. Exclusion criteria included cadaveric and animal studies. Registration status was correlated with entries from clinical trial registries. PB was determined by the proportion of trials presenting statistically significant results. ORB was evaluated by comparing the study's primary outcome with that listed in the trial registry. Trials quality was assessed using the Jadad score. RESULTS: After deleting duplicates, 7,561 citations were screened. 161 RCTs were eligible and included between 13 and 556 participants. Ninety one percent studied an adult population and 71% included patients suffering from primary open-angle glaucoma. Among included studies, 63% were not registered and 47% had statistically significant results. An upward trend in registration was observed with time. However, 37% of the studies showed discrepancies between objectives in cited clinical trial registries and the published results. CONCLUSION: Publication bias in surgical glaucoma trials was not obvious. Among the minority of trials that were registered, more than a third presented outcome reporting bias. Unregistered trials had lower quality. RCT registration is crucial for transparent interpretation of studies, improved patient care in surgery and informed decision-making.

Full article

Classification:

15 Miscellaneous



Issue 24-1

Change Issue


advertisement

Oculus